Literature DB >> 9048211

Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

T Ulyanova1, J Blasioli, M L Thomas.   

Abstract

An equilibrium between positive and negative regulation of immunoreceptor signaling leads to the proper execution of lymphocyte activation. Tyrosine phosphorylation is the initial event in antigen receptor-induced lymphocyte activation. It is generally accepted that protein tyrosine kinases are involved in positive regulation, whereas protein tyrosine phosphatases are important for the negative regulation of tyrosine phosphorylation-dependent processes. However, the interaction between protein tyrosine kinases and protein tyrosine phosphatases is complex. This article discusses the role of two protein tyrosine phosphatases. CD45 and SHP-1, in the regulation of immunoreceptor signaling. SHP-1 acts as a negative regulator for several immunoreceptors, including those for T- and B-cell antigen receptors. The major role of CD45 is in the positive regulation of T- and B-cell antigen receptor signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048211     DOI: 10.1007/BF02786326

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  115 in total

1.  Restoration of T cell receptor-mediated signal transduction by transfection of CD45 cDNA into a CD45-deficient variant of the Jurkat T cell line.

Authors:  G A Koretzky; M A Kohmetscher; T Kadleck; A Weiss
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso.

Authors:  L A Perkins; I Larsen; N Perrimon
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells.

Authors:  T Katagiri; M Ogimoto; K Hasegawa; K Mizuno; H Yakura
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

4.  Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro.

Authors:  D H Ng; J D Watts; R Aebersold; P Johnson
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

Review 5.  The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction.

Authors:  A C Chan; D M Desai; A Weiss
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway.

Authors:  G A Koretzky; J Picus; M L Thomas; A Weiss
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

7.  Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1.

Authors:  Y G Yeung; K L Berg; F J Pixley; R H Angeletti; E R Stanley
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

8.  Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes.

Authors:  U Dianzani; V Redoglia; F Malavasi; M Bragardo; A Pileri; C A Janeway; K Bottomly
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

9.  The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion.

Authors:  H M Lorenz; A S Lagoo; K J Hardy
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

10.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  7 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Authors:  Q Zhang; P N Raghunath; E Vonderheid; N Odum; M A Wasik
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  PD-1 signaling in primary T cells.

Authors:  James L Riley
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes.

Authors:  U Braun; K Rajewsky; R Pelanda
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.

Authors:  Yin Liu; Michael J Kruhlak; Jian-Jiang Hao; Stephen Shaw
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

Review 6.  The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.

Authors:  Kankana Bardhan; Theodora Anagnostou; Vassiliki A Boussiotis
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

7.  Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.

Authors:  Hamid Ali Nagi Al-Jamal; Siti Asmaa Mat Jusoh; Rosline Hassan; Muhammad Farid Johan
Journal:  BMC Cancer       Date:  2015-11-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.